Christopher Lemieux
6PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.Christopher Lemieux, John Kuruvilla, Mona Shafey
|Jan 27, 2026
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.Stephanie A Maier, Frédéric Barabé, Tobias Berg
|Oct 28, 2025
Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.Christopher Lemieux, Chai W Phua, K Sue Robinson
|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux
|Aug 27, 2025
Practical Guidance for the Expanded Implementation and Provision of Bispecific Antibodies for Diffuse Large B-Cell Lymphoma (DLBCL) Across Canada.David MacDonald, Robert Puckrin, Pamela Skrabek
|Mar 27, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic
Pageof 1
Frequent Collaborators
2 joint publications
Sylvie Lachance
2 joint publications
Mohamed Elemary
2 joint publications
Igor Novitzky-Basso
2 joint publications
Arjun Law
2 joint publications
Rajat Kumar
1 joint publications
Kylie Lepic
1 joint publications
David Allan
1 joint publications
Ram Vasudevan Nampoothiri
1 joint publications
Uday Deotare
1 joint publications
Irwin Walker
